RIVASTIGMINE 9.5 MG/24HR PATCH

rivastigmine
$1.6974per EA

Strength

9.5 mg/24h

Manufacturer

Sandoz Inc.

NDC

00781730931

Classification

Generic

Dosage Form

PATCH, EXTENDED RELEASE

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022083

On Market Since

9/2/2015

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

-2.6%

3M

-6.4%

6M

-10.0%

1Y

-6.4%

3Y

-13.4%

5Y

-52.0%

All

-83.9%